Epidemiology, prognosis and management of potassium disorders in Covid-19
- PMID: 34077995
- PMCID: PMC8209915
- DOI: 10.1002/rmv.2262
Epidemiology, prognosis and management of potassium disorders in Covid-19
Abstract
Coronavirus disease (Covid-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently the largest health crisis facing most countries. Several factors have been linked with a poor prognosis for this disease, including demographic factors, pre-existing comorbidities and laboratory parameters such as white blood cell count, D-dimer, C-reactive protein, albumin, lactate dehydrogenase, creatinine and electrolytes. Electrolyte abnormalities particularly potassium disorders are common among Covid-19 patients. Based on our pooled analysis, hypokalemia and hyperkalemia occur in 24.3% and 4.15% of Covid-19 patients, respectively. Potassium level deviation from the normal range may increase the chances of unfavorable outcomes and even death. Therefore, this article reviewed the epidemiology of potassium disorders and explained how hypokalemia and hyperkalemia are capable of deteriorating cardiac outcomes and the prognosis of Covid-19 for infected patients. The article finishes by highlighting some important considerations in the management of hypokalemia and hyperkalemia in these patients.
Keywords: Covid-19; SARS-CoV-2; hypokalemia; review; serum potassium.
© 2021 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there is no conflict of interests.
Figures


Similar articles
-
Potassium disorders in pediatric emergency department: Clinical spectrum and management.Arch Pediatr. 2020 Apr;27(3):146-151. doi: 10.1016/j.arcped.2019.12.003. Epub 2020 Jan 16. Arch Pediatr. 2020. PMID: 31955956
-
Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China.JAMA Netw Open. 2020 Jun 1;3(6):e2011122. doi: 10.1001/jamanetworkopen.2020.11122. JAMA Netw Open. 2020. PMID: 32525548 Free PMC article.
-
Potassium Disorders: Hypokalemia and Hyperkalemia.Am Fam Physician. 2015 Sep 15;92(6):487-95. Am Fam Physician. 2015. PMID: 26371733
-
Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.Adv Chronic Kidney Dis. 2017 Sep;24(5):315-318. doi: 10.1053/j.ackd.2017.06.004. Adv Chronic Kidney Dis. 2017. PMID: 29031358 Review.
-
Serum potassium concentrations: Importance of normokalaemia.Med Clin (Barc). 2017 Jun 21;148(12):562-565. doi: 10.1016/j.medcli.2017.03.013. Epub 2017 Apr 18. Med Clin (Barc). 2017. PMID: 28431898 Review. English, Spanish.
Cited by
-
Demographic features, laboratory findings and outcomes of ICU patients with COVID-19 in Ahvaz, Iran: A single-centered prospective study.J Family Med Prim Care. 2023 May;12(5):881-887. doi: 10.4103/jfmpc.jfmpc_1061_22. Epub 2023 May 31. J Family Med Prim Care. 2023. PMID: 37448932 Free PMC article.
-
Semi-quantitative CT score reflecting the degree of pulmonary infection as a risk factor of hypokalemia in COVID-19 patients: a cross-sectional study.Front Med (Lausanne). 2024 Oct 21;11:1366545. doi: 10.3389/fmed.2024.1366545. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39497851 Free PMC article.
-
SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19.Front Public Health. 2022 Jun 16;10:902123. doi: 10.3389/fpubh.2022.902123. eCollection 2022. Front Public Health. 2022. PMID: 35784208 Free PMC article.
-
The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance.Nutrients. 2022 Aug 21;14(16):3439. doi: 10.3390/nu14163439. Nutrients. 2022. PMID: 36014944 Free PMC article. Review.
-
Approaching Personalized Medicine: The Use of Machine Learning to Determine Predictors of Mortality in a Population with SARS-CoV-2 Infection.Biomedicines. 2024 Feb 9;12(2):409. doi: 10.3390/biomedicines12020409. Biomedicines. 2024. PMID: 38398012 Free PMC article.
References
-
- Huang L, Zhang X, Zhang X, et al. Rapid asymptomatic transmission of COVID‐19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16‐23 years outside Wuhan and characteristics of young patients with COVID‐19: a prospective contact‐tracing study. J Infect. 2020;80:e1‐e13. 10.1016/j.jinf.2020.03.006 - DOI - PMC - PubMed
-
- WHO coronavirus disease (COVID‐19) dashboard. https://covid19.who.int/2021
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous